MASS / 908 Devices: Not Worth Investing

908 Devices announced Q2 FY23 results with an 8.9% increase in revenue, driven by a 27% increase in MX908 device sales. The company experienced a sign more_horizontal

908 Devices, Inc. (NASDAQ:MASS ) Q2 2023 Earnings Conference Call August 8, 2023 8:30 AM ET Company Participants Kelly Gura - IR Kevin Knopp - Co-Foun more_horizontal

908 Devices Inc. (MASS) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to los more_horizontal

908 Devices Inc. (MASS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate more_horizontal

908 Devices Inc. (MASS) came out with a quarterly loss of $0.39 per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to los more_horizontal

908 Devices Inc. (MASS) delivered earnings and revenue surprises of -40.91% and 1.77%, respectively, for the quarter ended December 2022. Do the numbe more_horizontal

908 Devices is a highly rated stock by Wall Street analysts. Seeking Alpha quant ratings state the stock "is at a high risk of performing badly." more_horizontal

The niche healthcare company delivers a pair of convincing beats in its fourth quarter results. more_horizontal